To assess the efficacy and safety of once daily olmesartan medoxomil ( OM ) / amlodipine besylate ( AM ) / hydrochlorothiazide ( HCTZ ) 40/10/25 mg in patients with hypertension not at goal with mono , dual or triple drug therapy .